148260-92-8

Basic information

• Product Name: 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone
• Synonyms: 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone
• CAS NO: 148260-92-8
• Molecular Formula: C₂₆H₂₇NO₃
• Molecular Weight: 401.5
• Mol File: 148260-92-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 621.3°Cat760mmHg
• Flash Point: 329.6°C
• Appearance: /
• Density: 1.148g/cm³
• Vapor Pressure: 2.32E-15mmHg at 25°C
• Refractive Index: 1.591
• CAS DataBase Reference: 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone(148260-92-8)
• EPA Substance Registry System: 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone(148260-92-8)

Safety Data

• Hazardous Substances Data: 148260-92-8(Hazardous Substances Data)

Usage

General Description

1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone, also known as MDMPA, is a synthetic compound with potential pharmacological properties. It belongs to the class of azetidinone compounds and has been studied for its potential use in pharmaceuticals. MDMPA has been found to exhibit anti-inflammatory and analgesic properties, making it a potential candidate for the treatment of conditions such as pain, inflammation, and other related ailments. Its chemical structure contains methoxyphenyl and phenylpropyl groups, which contribute to its pharmacological activities. Further research is needed to fully understand the potential therapeutic applications of this compound.

InChI:InChI=1/C26H27NO3/c1-29-22-15-11-20(12-16-22)25-24(10-6-9-19-7-4-3-5-8-19)26(28)27(25)21-13-17-23(30-2)18-14-21/h3-5,7-8,11-18,24-25H,6,9-10H2,1-2H3/t24-,25-/m1/s1

Upstream product

• 107617-02-7 phenylvaleric acid (1R,2S,5R)-menthyl ester 
• 158962-65-3 phenylvaleric acid (1S,2R,5S)-menthyl ester 
• 1624-46-0 (E)-1,N-bis(4-methoxyphenyl)methanimine 
• 2270-20-4 5-Phenylpentanoic acid 
• 263559-17-7 (3'R,3S,4S)-1,4-di(4-methoxyphenyl)-3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-phenylpropyl]azetidin-2-one 
• 263559-11-1 (3'R,3S,4S)-1,4-di(4-methoxyphenyl)-3-[(1-hydroxy-3-phenyl)propyl]azetidin-2-one 
• 263559-19-9 C₂₃H₄₂O₃Si₂ 
• 263559-16-6 (3R)-S-2-pyridylthio 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-phenylvalerate 
• 17071-29-3 ethyl 3-oxo-5-phenylpentanoate 
• 153744-07-1 (R)-3-hydroxy-5-phenylvaleric acid 
• 263559-23-5 Imidazole-1-carbothioic acid O-{(R)-1-[(2S,3S)-1,2-bis-(4-methoxy-phenyl)-4-oxo-azetidin-3-yl]-3-phenyl-propyl} ester 
• 148260-85-9 (3S,4S)-1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone 
• 20371-41-9 5-phenylvaleric acid chloride 
• 263559-20-2 3-(tert-butyl-dimethyl-silanyloxy)-5-phenyl-pentanoic acid 

Relevant articles and documents

A simple stereoselective synthesis of the cholesterol absorption inhibitor (-)-SCH 48461

The cholesterol absorption inhibitor (3R,4S)-1 is synthesized in 91% ee by a stereoselective condensation of doubly deprotonated ester 2 and imine 3. The optical purity of the trans-diastereomer 1 obtained as the major isomer (trans/cis, 94:6) is enhanced to >98% ee by a single recrystallization.

Asymmetric Synthesis and Absolute Stereochemistry of Cholesterol Absorption Inhibitor, SCH 484661.

The first asymmetric synthesis of cholesterol absorption inhibitor, SCH 48461 is described.The compound was prepared from an asymmetric ester enolate-imine condensation using Oppolzer's chiral ester or the corresponding menthol ester as the stereocontroll